L&C Bio is a bio enterprise that manufactures and sells tissue engineering treatment materials such as human tissue grafts and human tissue-based medical devices, as well as cosmeceuticals, based on specialized knowledge of skin. It operates a pharmaceutical business leveraging its existing surgical network, a CRO business for functional cosmetics and health functional foods, and a medical AI & CT imaging equipment business. The company has localized allogeneic dermal grafts, expanding product indications, and is leading the human tissue graft industry by entering the global market with next-generation human tissue-based medical devices.

Human tissue-based polymer medical device : Maximizes the functions of medical devices through combination with various polymers to improve the therapeutic effect of human tissues. Xenograft based medical device : We are not limited to human tissue, but strive to expand the treatment area and meet the needs of patients by utilizing heterogeneous tissue. Human tissue graft material : Through L&C BIO's specialized AlloClean® process, various human tissues are commercialized to broaden the scope of use of graft materials, and improve patient health recovery and convenience in the medical field. Next generation medical device : We create a one-to-one process through the development of customized medical devices with the form and function required by consumers, such as 3D printing, to increase satisfaction while leading the latest trends

Public

etc